Functional p53 status as a biomarker for chemotherapy response in oral-cavity cancer.
Mroz
Edmund A
EA
Rocco
James W
JW
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D004252:DNA Mutational Analysis; D018572:Disease-Free Survival; D005472:Fluorouracil / Q000008:administration & dosage; D005820:Genetic Testing; D006801:Humans; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000601:surgery; D009154:Mutation; D020360:Neoadjuvant Therapy; D019647:Oral Surgical Procedures; D018579:Patient Selection; D011237:Predictive Value of Tests; D013997:Time Factors; D015533:Transcriptional Activation; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
D014408:Biomarkers, Tumor; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D002945:Cisplatin; D005472:Fluorouracil